DaVita (DVA) Competitors $143.43 +0.88 (+0.61%) Closing price 03:59 PM EasternExtended Trading$143.38 -0.04 (-0.03%) As of 05:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock DVA vs. ALGN, DXCM, HQY, MMSI, CAH, COR, EHC, HAE, ITGR, and MCKShould you be buying DaVita stock or one of its competitors? The main competitors of DaVita include Align Technology (ALGN), DexCom (DXCM), HealthEquity (HQY), Merit Medical Systems (MMSI), Cardinal Health (CAH), Cencora (COR), Encompass Health (EHC), Haemonetics (HAE), Integer (ITGR), and McKesson (MCK). These companies are all part of the "medical" sector. DaVita vs. Its Competitors Align Technology DexCom HealthEquity Merit Medical Systems Cardinal Health Cencora Encompass Health Haemonetics Integer McKesson DaVita (NYSE:DVA) and Align Technology (NASDAQ:ALGN) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends. Is DVA or ALGN more profitable? Align Technology has a net margin of 10.29% compared to DaVita's net margin of 6.63%. DaVita's return on equity of 176.11% beat Align Technology's return on equity.Company Net Margins Return on Equity Return on Assets DaVita6.63% 176.11% 4.66% Align Technology 10.29%13.52%8.36% Do analysts prefer DVA or ALGN? DaVita presently has a consensus price target of $164.50, suggesting a potential upside of 14.69%. Align Technology has a consensus price target of $242.92, suggesting a potential upside of 21.88%. Given Align Technology's stronger consensus rating and higher probable upside, analysts plainly believe Align Technology is more favorable than DaVita.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DaVita 1 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Align Technology 1 Sell rating(s) 4 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.67 Do institutionals & insiders hold more shares of DVA or ALGN? 90.1% of DaVita shares are owned by institutional investors. Comparatively, 88.4% of Align Technology shares are owned by institutional investors. 2.0% of DaVita shares are owned by insiders. Comparatively, 0.7% of Align Technology shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media prefer DVA or ALGN? In the previous week, Align Technology had 9 more articles in the media than DaVita. MarketBeat recorded 18 mentions for Align Technology and 9 mentions for DaVita. DaVita's average media sentiment score of 1.24 beat Align Technology's score of 1.13 indicating that DaVita is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DaVita 8 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Align Technology 10 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable earnings & valuation, DVA or ALGN? DaVita has higher revenue and earnings than Align Technology. DaVita is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDaVita$12.82B0.84$936.34M$10.0914.21Align Technology$4.00B3.61$421.36M$5.4936.30 Which has more volatility and risk, DVA or ALGN? DaVita has a beta of 1.11, suggesting that its stock price is 11% more volatile than the S&P 500. Comparatively, Align Technology has a beta of 1.63, suggesting that its stock price is 63% more volatile than the S&P 500. SummaryAlign Technology beats DaVita on 10 of the 17 factors compared between the two stocks. Get DaVita News Delivered to You Automatically Sign up to receive the latest news and ratings for DVA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DVA vs. The Competition Export to ExcelMetricDaVitaMED IndustryMedical SectorNYSE ExchangeMarket Cap$10.83B$3.85B$5.53B$20.66BDividend YieldN/A1.34%5.06%3.71%P/E Ratio14.2135.6828.5827.83Price / Sales0.8417.61372.6456.10Price / Cash7.4522.9324.7217.94Price / Book29.694.368.234.60Net Income$936.34M$189.47M$3.19B$989.58M7 Day Performance0.50%-0.35%5.46%1.16%1 Month Performance5.51%-4.53%9.39%5.49%1 Year Performance1.33%-0.38%30.48%10.60% DaVita Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DVADaVita4.4536 of 5 stars$143.43+0.6%$164.50+14.7%+0.6%$10.83B$12.82B14.2176,000Positive NewsALGNAlign Technology4.6072 of 5 stars$193.83-1.5%$241.25+24.5%-16.6%$14.05B$3.98B35.3120,945Positive NewsDXCMDexCom4.7833 of 5 stars$82.94+0.0%$98.50+18.8%-26.9%$32.52B$4.03B61.9010,300Positive NewsHQYHealthEquity3.3564 of 5 stars$101.83-0.3%$118.09+16.0%+23.6%$8.81B$1.20B74.333,120Positive NewsMMSIMerit Medical Systems4.3212 of 5 stars$91.12-2.6%$109.11+19.7%+8.3%$5.39B$1.36B44.677,400Positive NewsCAHCardinal Health4.8931 of 5 stars$167.62+1.6%$157.43-6.1%+71.0%$40.01B$226.83B26.1548,900Positive NewsCORCencora4.5206 of 5 stars$302.43+2.1%$306.33+1.3%+32.6%$58.62B$293.96B35.0846,000Positive NewsEHCEncompass Health4.9165 of 5 stars$119.22+0.2%$127.00+6.5%+36.9%$12.02B$5.37B24.6340,000News CoverageAnalyst RevisionHAEHaemonetics4.9135 of 5 stars$75.00-2.4%$96.80+29.1%-16.6%$3.60B$1.36B22.663,023Analyst ForecastAnalyst RevisionITGRInteger2.8793 of 5 stars$117.05-3.3%$145.00+23.9%-0.4%$4.08B$1.72B55.4711,000MCKMcKesson4.5327 of 5 stars$735.41+2.2%$696.42-5.3%+22.9%$92.01B$359.05B28.4745,000Positive NewsAnalyst Downgrade Related Companies and Tools Related Companies ALGN Competitors DXCM Competitors HQY Competitors MMSI Competitors CAH Competitors COR Competitors EHC Competitors HAE Competitors ITGR Competitors MCK Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:DVA) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAn extra $1,000 per month?A little-known Title 15 provision could let you collect instant payouts — $100 to $1,000 — directly from your ...TradeSmith | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DaVita Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DaVita With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
